Evaluation of the protective efficacy of a spatial repellent to reduce malaria incidence in children in western Kenya compared to placebo: study protocol for a cluster-randomized double-blinded control trial (the AEGIS program).

Eric O OchomoJohn E GimnigAchuyt BhattaraiAaron M SamuelsSimon KariukiGeorge OkelloBernard Abong'oEunice A OumaJackline KosgeiStephen MungaKiambo NjagiWycliffe OdongoFang LiuJohn P GriecoNicole L Achee

Published in: Trials (2022)

ClinicalTrials.gov NCT04766879 . Registered February 23, 2021.

Keyphrases

double blind
phase iii
placebo controlled
open label
young adults
clinical trial
risk factors
quality improvement
south africa
plasmodium falciparum
phase ii
randomized controlled trial